2010Journal of Medical ForumRequires access

Valsartan Treatment of Chronic Congestive Heart Failure

LI Hongcai

Open publisher page 0 citations

Abstract

Objective Angiotensin Ⅱ receptor antagonist (valsartan) in the treatment of chronic congestive heart failure.Methods Totally 160 patients with chronic congestive heart failure were randomly divided into treatment group and control group 80 cases,two groups were given conventional anti-failure therapy in the treatment group on the basis of conventional therapy plus valsartan 80~160mg,oral,1 time/d,once every 12 weeks of treatment,clinical symptoms and cardiac function improvement.Results The total effective rate was 96.3% in the treatnent group and 77.5% in the control group,2 groups were significantly different (P0.05).Conclusion Valsartan in chronic congestive heart failure can improve clinical efficacy.

About this research paper

What this paper is about

Objective Angiotensin Ⅱ receptor antagonist (valsartan) in the treatment of chronic congestive heart failure.Methods Totally 160 patients with chronic congestive heart failure were randomly divided into treatment group and control group 80 cases,two groups were given conventional anti-failure therapy in the treatment group on the basis of conventional therapy plus valsartan 80~160mg,oral,1 time/d,once every 12 weeks of treatment,clinical symptoms and cardiac function improvement.Results The total effective rate was 96.3% in the treatnent group and 77.5% in the control group,2 groups were significantly different (P0.05).Conclusion Valsartan in chronic congestive heart failure can improve clinical efficacy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective Angiotensin Ⅱ receptor antagonist (valsartan) in the treatment of chronic congestive heart failure.Methods Totally 160 patients with chronic congestive heart failure were randomly divided into treatment group and control group 80 cases,two groups were given conventional anti-failure therapy in the treatment group on the basis of conventional therapy plus valsartan 80~160mg,oral,1 time/d,once every 12 weeks of treatment,clinical symptoms and cardiac function improvement.Results The total effective rate was 96.3% in the treatnent group and 77.5% in the control group,2 groups were significantly different (P0.05).Conclusion Valsartan in chronic congestive heart failure can improve clinical efficacy.

Key concepts: Valsartan, Heart failure, Medicine, Cardiology, Internal medicine, Cardiac function curve, Antagonist, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Valsartan Treatment of Chronic Congestive Heart Failure — Research Paper | ScholarLens